Skin Squamous Cell Carcinoma of the trunk and limbs: Role of Sentinel Node Biopsy in its staging

Revista Colombiana de Cancerología

View Publication Info
 
 
Field Value
 
Title Skin Squamous Cell Carcinoma of the trunk and limbs: Role of Sentinel Node Biopsy in its staging
Carcinoma escamocelular cutáneo del tronco y las extremidades: utilidad del ganglio centinela en su estadificación
 
Creator Contreras Pérez, Daniel Fernando
Molina Jiménez, Juan Pablo
Díaz Casas, Sandra Esperanza
 
Subject Squamous cell carcinoma
Squamous Cell Neoplasms
Skin Neoplasms
Sentinel Lymph Node Biopsy
Lymph Node Excision
Lymph Nodes
Extremities
Limbs
Carcinoma de células escamosas
Neoplasia de células escamosas
Neoplasias cutáneas
Biopsia del ganglio linfático centinela
Escisión del ganglio linfático
Ganglios linfáticos
Extremidades
 
Description Squamous Cell Carcinoma (SCC) is associated with a more aggressive biological behaviour in the presence of risk factors. High risk SCC may present with lymph node metastasis in 21% of patients, with the consequent reduction in overall survival. The physical examination lymph nodes can have a false-negative rate between 15% and 39%, thus requiring the need to find a new diagnostic tool that allows a more precise evaluation of lymph node involvement.Sentinel lymph node biopsy has been reported in case series of patients with head and neck SCC, and genital SCC, but there are few case reports about skin SCC of the trunk and extremities.The aim of this review is to describe the indications and feasibility of using sentinel lymph node biopsy to assess lymph node status in patients with skin SCC of trunk and limbs.
El carcinoma escamocelular (CEC) tiene un comportamiento biológico más agresivo cuando exhibe factores de riesgo. En este grupo, se comprometen los ganglios linfáticos hasta en 21% de los casos lo que disminuye la supervivencia a 5 años. El examen clínico de las cadenas ganglionares puede tener una tasa de falsos negativos cercana a 39%, determinando la necesidad de una herramienta que permita evaluar el compromiso ganglionar de un modo más preciso.La biopsia del ganglio centinela ha sido documentada en la estadificación del CEC de cabeza y cuello, y el CEC de origen anogenital, pero en estas series de casos hay un escaso número de pacientes correspondientes a CEC cutáneo del tronco y las extremidades. El objetivo de esta revisión es describir las indicaciones y la plausibilidad de estadificar la extensión ganglionar usando la biopsia de ganglio centinela en pacientes con CEC cutáneo del tronco y extremidades.
 
Publisher Instituto Nacional de Cancerología
 
Date 2018-03-01
 
Type info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
 
Format application/pdf
 
Identifier https://www.revistacancercol.org/index.php/cancer/article/view/172
 
Source Revista Colombiana de Cancerología; Vol 22 No 1 (2018); 39-45
Revista Colombiana de Cancerología; Vol. 22 Núm. 1 (2018); 39-45
Revista Colombiana de Cancerología; v. 22 n. 1 (2018); 39-45
2346-0199
0123-9015
 
Language spa
 
Relation https://www.revistacancercol.org/index.php/cancer/article/view/172/52
/*ref*/Baykal C, Yazganoglu KD. Malignant Epithelial Tumors. En: Baykal C, Yazganoglu KD, editores. Clinical Atlas of Skin Tumors. Springer; 2014. p. 296-334. https://doi.org/10.1007/978-3-642-40938-7_11
/*ref*/Bhambri SD, Scott. Bhambri, Avani Squamous Cell Carcinoma. En: Rigel DS, editores. Cancer of the Skin. Second edition ed. Elsevier Inc.; 2011. p. 124-39. https://doi.org/10.1016/B978-1-4377-1788-4.00012-5
/*ref*/Alam M, Ratner D. Cutaneous squamous-cell carcinoma. N Engl J Med. 2001;344:975-83. https://doi.org/10.1056/NEJM200103293441306
/*ref*/Karia PS, Han J, Schmults CD. Cutaneous squamous cell carcinoma: estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012. J Am Acad Dermatol. 2013;68:957-66. https://doi.org/10.1016/j.jaad.2012.11.037
/*ref*/Brougham ND, Dennett ER, Cameron R, Tan ST. The incidence of metastasis from cutaneous squamous cell carcinoma and the impact of its risk factors. J Surg Oncol. 2012;106:811-5. https://doi.org/10.1002/jso.23155
/*ref*/Brantsch KD, Meisner C, Schönfisch B, Trilling B, Wehner-Caroli J, Röcken M, et al. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Lancet Oncol. 2008;9:713-20. https://doi.org/10.1016/S1470-2045(08)70178-5
/*ref*/Instituto Nacional de Cancerología. Anuario Estadístico 2012. Bogotá, 2015.
/*ref*/Schmitt AR, Brewer JD, Bordeaux JS, Baum CL. Staging for cutaneous squamous cell carcinoma as a predictor of sentinel lymph node biopsy results: meta-analysis of American Joint Committee on Cancer criteria and a proposed alternative system. JAMA Dermatol. 2014;150:19-24. https://doi.org/10.1001/jamadermatol.2013.6675
/*ref*/Renzi C, Caggiati A, Mannooranparampil TJ, Passarelli F, Tartaglione G, Pennasilico GM, et al. Sentinel lymph node biopsy for high risk cutaneous squamous cell carcinoma: case series and review of the literature. Eur J Surg Oncol. 2007;33:364-9. https://doi.org/10.1016/j.ejso.2006.10.017
/*ref*/Joseph MG, Zulueta WP, Kennedy PJ. Squamous cell carcinoma of the skin of the trunk and limbs: the incidence of metastases and their outcome. Aust N Z J Surg. 1992;62:697-701. https://doi.org/10.1111/j.1445-2197.1992.tb07065.x
/*ref*/Weinberg AS, Ogle CA, Shim EK. Metastatic cutaneous squamous cell carcinoma: an update. Dermatol Surg. 2007;33: 885-99. https://doi.org/10.1097/00042728-200708000-00001
/*ref*/Ross AS, Schmults CD. Sentinel lymph node biopsy in cutaneous squamous cell carcinoma: a systematic review of the English literature. Dermatol Surg. 2006;32:1309-21. https://doi.org/10.1111/j.1524-4725.2006.32300.x
/*ref*/North JH, Spellman JE, Driscoll D, Velez A, Kraybill WG, Petrelli NJ. Advanced cutaneous squamous cell carcinoma of the trunk and extremity: analysis of prognostic factors. J Surg Oncol. 1997;64:212-7. https://doi.org/10.1002/(SICI)1096-9098(199703)64:3<212::AID-JSO7>3.0.CO;2-D
/*ref*/Cherpelis BS, Marcusen C, Lang PG. Prognostic factors for metastasis in squamous cell carcinoma of the skin. Dermatol Surg. 2002;28:268-73. https://doi.org/10.1046/j.1524-4725.2002.01169.x
/*ref*/Mullen JT, Feng L, Xing Y, Mansfield PF, Gershenwald JE, Lee JE, et al. Invasive squamous cell carcinoma of the skin: defining a high-risk group. Ann Surg Oncol. 2006;13:902-9. https://doi.org/10.1245/ASO.2006.07.022
/*ref*/Schmults CD, Karia PS, Carter JB, Han J, Qureshi AA. Factors predictive of recurrence and death from cutaneous squamous cell carcinoma: a 10-year, single-institution cohort study. JAMA Dermatol. 2013;149:541-7. https://doi.org/10.1001/jamadermatol.2013.2139
/*ref*/Reule RB, Golda NJ, Wheeland RG. Treatment of cutaneous squamous cell carcinoma with perineural invasion using Mohs micrographic surgery: report of two cases and review of the literature. Dermatol Surg. 2009;35:1559-66. https://doi.org/10.1111/j.1524-4725.2009.01276.x
/*ref*/Krediet JT, Beyer M, Lenz K, Ulrich C, Lange-Asschenfeldt B, Stockfleth E, et al. Sentinel lymph node biopsy and risk factors for predicting metastasis in cutaneous squamous cell carcinoma. Br J Dermatol. 2015;172:1029-36. https://doi.org/10.1111/bjd.13508
/*ref*/Thompson AK, Kelley BF, Prokop LJ, Murad MH, Baum CL. Risk Factors for Cutaneous Squamous Cell Carcinoma Recurrence, Metastasis, and Disease-Specific Death: A Systematic Review and Meta-analysis. JAMA Dermatol. 2016;152:419-28. https://doi.org/10.1001/jamadermatol.2015.4994
/*ref*/(SIGN). SIGN. Management of primary cutaneous squamous cell carcinoma. Edinburgh: SIGN; 2014. June 2014 [(SIGN publication no. 140)]. Disponible en: http://www.sign.ac.uk/pdf/SIGN140.pdf
/*ref*/Rowe DE, Carroll RJ, Day CL. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol. 1992;26:976-90. https://doi.org/10.1016/0190-9622(92)70144-5
/*ref*/Reschly MJ, Messina JL, Zaulyanov LL, Cruse W, Fenske NA. Utility of sentinel lymphadenectomy in the management of patients with high-risk cutaneous squamous cell carcinoma. Dermatol Surg. 2003;29:135-40. https://doi.org/10.1046/j.1524-4725.2003.29035.x
/*ref*/Breuninger H, Schaumburg-Lever G, Holzschuh J, Horny HP. Desmoplastic squamous cell carcinoma of skin and vermilion surface: a highly malignant subtype of skin cancer. Cancer. 1997;79:915-9. https://doi.org/10.1002/(SICI)1097-0142(19970301)79:5<915::AID-CNCR7>3.0.CO;2-A
/*ref*/NCCN. Squamous Cell Skin Cancer (Guideline Version 1.2016) Disponible en: https://www.nccn.org/professionals/physician_gls/pdf/squamous.pdf
/*ref*/García O, Díaz S, Vergara E, Duarte C, Ángel J, Villamizar L, et al. Sentinel Node in Cutaneous Malignant Melanoma in the Trunk and Extremities: Experience at the National Cancer Institute, Bogotá, Colombia, 2000-2007. Rev Colomb Cancerol. 2011;15:119-26. https://doi.org/10.1016/S0123-9015(11)70060-9
/*ref*/Michl C, Starz H, Bachter D, Balda BR. Sentinel lymphonodectomy in nonmelanoma skin malignancies. Br J Dermatol. 2003;149:763-9. https://doi.org/10.1046/j.1365-2133.2003.05578.x
/*ref*/Lane JE, Kent DE. Surgical margins in the treatment of nonmelanoma skin cancer and mohs micrographic surgery. Curr Surg. 2005;62:518-26. https://doi.org/10.1016/j.cursur.2005.01.003
/*ref*/Lansbury L, Bath-Hextall F, Perkins W, Stanton W, Leonardi-Bee J. Interventions for non-metastatic squamous cell carcinoma of the skin: systematic review and pooled analysis of observational studies. BMJ. 2013;347:f6153. https://doi.org/10.1136/bmj.f6153
/*ref*/Brodland DG, Zitelli JA. Surgical margins for excision of primary cutaneous squamous cell carcinoma. J Am Acad Dermatol. 1992;27:241-8. https://doi.org/10.1016/0190-9622(92)70178-I
/*ref*/Palyca P, Koshenkov VP, Mehnert JM. Developments in the treatment of locally advanced and metastatic squamous cell carcinoma of the skin: a rising unmet need. Am Soc Clin Oncol Educ Book. 2014:e397-404. https://doi.org/10.14694/EdBook_AM.2014.34.e397
/*ref*/Farasat S, Yu SS, Neel VA, Nehal KS, Lardaro T, Mihm MC, et al. A new American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: creation and rationale for inclusion of tumor (T) characteristics. J Am Acad Dermatol.2011;64:1051-9. https://doi.org/10.1016/j.jaad.2010.08.033
/*ref*/Knappe M, Louw M, Gregor RT. Ultrasonography-guided fine needle aspiration for the assessment of cervical metastases. Arch Otolaryngol Head Neck Surg. 2000;126:1091-6. https://doi.org/10.1001/archotol.126.9.1091
/*ref*/Land R, Herod J, Moskovic E, King M, Sohaib SA, Trott P, et al. Routine computerized tomography scanning, groin ultrasound with or without fine needle aspiration cytology in the surgical management of primary squamous cell carcinoma of the vulva. Int J Gynecol Cancer. 2006;16:312-7. https://doi.org/10.1111/j.1525-1438.2006.00340.x
/*ref*/Salguero-Fernández I, Rios-Buceta L, Jaén-Olasolo P. [Sentinel lymph node in nonmelanoma skin cancer]. Actas Dermosifiliogr. 2011;102:589-98. https://doi.org/10.1016/j.ad.2011.05.010
/*ref*/Morton DL, Thompson JF, Essner R, Elashoff R, Stern SL, Nieweg OE, et al. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. Ann Surg. 1999;230: 453-63. https://doi.org/10.1097/00000658-199910000-00001
/*ref*/Gershenwald JE, Thompson W, Mansfield PF, Lee JE, Colome MI, Tseng CH, et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol. 1999;17:976-83. https://doi.org/10.1200/JCO.1999.17.3.976
/*ref*/Krag D, Weaver D, Ashikaga T, Moffat F, Klimberg VS, Shriver C, et al. The sentinel node in breast cancer-a multicenter validation study. N Engl J Med. 1998;339:941-6. https://doi.org/10.1056/NEJM199810013391401
/*ref*/McMasters KM, Tuttle TM, Carlson DJ, Brown CM, Noyes RD, Glaser RL, et al. Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi institutional practice when optimal technique is used. J Clin Oncol. 2000;18:2560-6. https://doi.org/10.1200/JCO.2000.18.13.2560
/*ref*/McMasters KM, Noyes RD, Reintgen DS, Goydos JS, Beitsch PD, Davidson BS, et al. Lessons learned from the Sunbelt Melanoma Trial. J Surg Oncol. 2004;86:212-23. https://doi.org/10.1002/jso.20084
/*ref*/Berk DR, Johnson DL, Uzieblo A, Kiernan M, Swetter SM. Sentinel lymph node biopsy for cutaneous melanoma: the Stanford experience, 1997-2004. Arch Dermatol. 2005;141:1016-22. https://doi.org/10.1001/archderm.141.8.1016
/*ref*/Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Elashoff R, Essner R, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med. 2006;355:1307-17. https://doi.org/10.1056/NEJMoa060992
/*ref*/Johnson TM, Sondak VK, Bichakjian CK, Sabel MS. The role of sentinel lymph node biopsy for melanoma: evidence assessment. J Am Acad Dermatol. 2006;54:19-27. https://doi.org/10.1016/j.jaad.2005.09.029
/*ref*/Wagner JD, Evdokimow DZ, Weisberger E, Moore D, Chuang TY, Wenck S, et al. Sentinel node biopsy for high-risk nonmelanoma cutaneous malignancy. Arch Dermatol. 2004;140:75-9. https://doi.org/10.1001/archderm.140.1.75
/*ref*/Altinyollar H, Berbero˘glu U, Celen O. Lymphatic mapping and sentinel lymph node biopsy in squamous cell carcinoma of the lower lip. Eur J Surg Oncol. 2002;28:72-4. https://doi.org/10.1053/ejso.2001.1206
/*ref*/Nouri K, Rivas MP, Pedroso F, Bhatia R, Civantos F. Sentinel lymph node biopsy for high-risk cutaneous squamous cell carcinoma of the head and neck. Arch Dermatol. 2004;140:1284. https://doi.org/10.1001/archderm.140.10.1284-a
/*ref*/Eastman AL, Erdman WA, Lindberg GM, Hunt JL, Purdue GF, Fleming JB. Sentinel lymph node biopsy identifies occult nodal metastases in patients with Marjolin's ulcer. J Burn Care Rehabil. 2004;25:241-5. https://doi.org/10.1097/01.BCR.0000124791.17426.58
/*ref*/Ali S, Tiwari RM, Snow GB. False-positive and false-negative neck nodes. Head Neck Surg. 1985;8:78-82. https://doi.org/10.1002/hed.2890080204
/*ref*/Sloan P. Head and neck sentinel lymph node biopsy: current state of the art. Head Neck Pathol. 2009;3:231-7. https://doi.org/10.1007/s12105-009-0132-3
/*ref*/Ozc¸elik D, Tatlidede S, Hacikerim S, U˘gurlu K, Atay M. The use of sentinel lymph node biopsy in squamous cell carcinoma of the foot: a case report. J Foot Ankle Surg. 2004;43:60-3. https://doi.org/10.1053/j.jfas.2003.11.003
/*ref*/Hatta N, Morita R, Yamada M, Takehara K, Ichiyanagi K, Yokoyama K. Implications of popliteal lymph node detected by sentinel lymph node biopsy. Dermatol Surg. 2005;31:327-30. https://doi.org/10.1097/00042728-200503000-00014
/*ref*/Cuccia G, Colonna MR, Papalia I, Manasseri B, Romeo M, d'Alcontres FS. The use of sentinel node biopsy and selective lymphadenectomy in squamous cell carcinoma of the upper limb. Usefulness of sentinel node biopsy to avoid useless lymphadenectomies in high-risk upper limb SCC. Ann Ital Chir. 2008;79:67-71.
/*ref*/Liu YY, Rozen WM, Rahdon R. Sentinel lymph node biopsy for squamous cell carcinoma of the extremities: case report and review of the literature. Anticancer Res. 2011;31:1443-6.
/*ref*/Stadelmann WK, Javaheri S, Cruse CW, Reintgen DS. The use of selective lymphadenectomy in squamous cell carcinoma of the wrist: a case report. J Hand Surg Am. 1997;22:726-31. https://doi.org/10.1016/S0363-5023(97)80136-0
/*ref*/Yamada M, Hatta N, Sogo K, Komura K, Hamaguchi Y, Takehara K. Management of squamous cell carcinoma in a patient with recessive-type epidermolysis bullosa dystrophica. Dermatol Surg. 2004;30:1424-9. https://doi.org/10.1111/j.1524-4725.2004.30440.x
/*ref*/Perez-Naranjo L, Herrera-Saval A, Garcia-Bravo B, Perez-Bernal AM, Camacho F. Sentinel lymph node biopsy in recessive dystrophic epidermolysis bullosa and squamous cell carcinoma. Arch Dermatol. 2005;141:110-1. https://doi.org/10.1001/archderm.141.1.110
/*ref*/Sahn RE, Lang PG. Sentinel lymph node biopsy for high-risk nonmelanoma skin cancers. Dermatol Surg. 2007;33:786-92. https://doi.org/10.1097/00042728-200707000-00002
/*ref*/Fujiwara M, Mizukami T, Suzuki A, Fukamizu H. Sentinel lymph node detection in skin cancer patients using real-time fluorescence navigation with indocyanine green: preliminary experience. J Plast Reconstr Aesthet Surg. 2009;62:e373-8. https://doi.org/10.1016/j.bjps.2007.12.074
/*ref*/Kwon S, Dong ZM, Wu PC. Sentinel lymph node biopsy for highrisk cutaneous squamous cell carcinoma: clinical experience and review of literature. World J Surg Oncol. 2011;9:80. https://doi.org/10.1186/1477-7819-9-80
/*ref*/Jambusaria-Pahlajani A, Kanetsky PA, Karia PS, Hwang WT, Gelfand JM, Whalen FM, et al. Evaluation of AJCC tumor staging for cutaneous squamous cell carcinoma and a proposed alternative tumor staging system. JAMA Dermatol. 2013;149:402-10. https://doi.org/10.1001/jamadermatol.2013.2456
/*ref*/Veness MJ, Palme CE, Morgan GJ. High-risk cutaneous squamous cell carcinoma of the head and neck: results from 266 treated patients with metastatic lymph node disease. Cancer. 2006;106:2389-96. https://doi.org/10.1002/cncr.21898
/*ref*/Terada KY, Shimizu DM, Wong JH. Sentinel node dissection and ultrastaging in squamous cell cancer of the vulva. Gynecol Oncol. 2000;76:40-4. https://doi.org/10.1006/gyno.1999.5660
/*ref*/Diaz S, Molina J, Contreras D, Lopez D, Garcia O, García M, et al. Sentinel node in squamous cell carcinoma of the skin at the trunk and extremities: Experience in a Latin American reference center. Publishing process.
 

Contact Us

The PKP Index is an initiative of the Public Knowledge Project.

For PKP Publishing Services please use the PKP|PS contact form.

For support with PKP software we encourage users to consult our wiki for documentation and search our support forums.

For any other correspondence feel free to contact us using the PKP contact form.

Find Us

Twitter

Copyright © 2015-2018 Simon Fraser University Library